english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Wholly self-financed through subscriptions, Prescrire makes its accounts public every year

Metopimazine: cardiac disorders

In the May issue of Prescrire International: Psychiatric disorders following in utero exposure to diethylstilbestrol (DES)

Exploratory trials, surrogate endpoints: not a robust basis for marketing authorisation

New cancer drugs: poorly evaluated, ineffective and overpriced

Warts: beware of acid-based wart removers

"Preventing Overdiagnosis 2018": an international conference in Copenhagen, 20-22 August 2018

Treating intermittent claudication: first encourage patients to follow a walking exercise programme

In the April issue of Prescrire International: Towards better patient care - drugs to avoid in 2018

Hepatitis C: sofosbuvir + velpatasvir (Epclusa°) represents an advance for some patients

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90